PROTHENA CORPORATION PLC - ORDINARY SHARES

Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease

28 3 2022 07:30:00 提供 Nasdaq GlobeNewswire

Prothena to Participate in Stifel 2022 Virtual CNS Days

21 3 2022 15:05:00 提供 Nasdaq GlobeNewswire

Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022

16 3 2022 04:30:00 提供 Nasdaq GlobeNewswire

Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights

17 2 2022 15:05:01 提供 Nasdaq GlobeNewswire

Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022

10 2 2022 15:05:00 提供 Nasdaq GlobeNewswire

Prothena to Participate in JMP Securities Hematology and Oncology Summit

29 11 2021 15:05:00 提供 Nasdaq GlobeNewswire

Prothena Reports Third Quarter 2021 Financial Results and Business Highlights

04 11 2021 15:05:02 提供 Nasdaq GlobeNewswire

Prothena to Report Third Quarter 2021 Financial Results on November 4th

28 10 2021 15:05:01 提供 Nasdaq GlobeNewswire

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 10 2021 15:30:00 提供 Nasdaq GlobeNewswire

Prothena Announces Executive Appointments

01 10 2021 15:05:00 提供 Nasdaq GlobeNewswire

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

03 9 2021 15:05:00 提供 Nasdaq GlobeNewswire

Prothena to Participate in Upcoming September Healthcare Conferences

01 9 2021 15:05:00 提供 Nasdaq GlobeNewswire

Prothena Reports Second Quarter 2021 Financial Results and Business Highlights

05 8 2021 15:05:02 提供 Nasdaq GlobeNewswire

Prothena to Report Second Quarter 2021 Financial Results on August 5th

29 7 2021 15:05:00 提供 Nasdaq GlobeNewswire

Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021

26 7 2021 08:00:00 提供 Nasdaq GlobeNewswire

Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Conference 2021

20 7 2021 15:05:00 提供 Nasdaq GlobeNewswire

Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme

12 7 2021 06:00:00 提供 Nasdaq GlobeNewswire

Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and Development Collaboration

24 6 2021 07:30:00 提供 Nasdaq GlobeNewswire

Prothena to Participate in JMP Securities Life Sciences Conference on June 16

10 6 2021 13:18:16 提供 Nasdaq GlobeNewswire

Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors

20 5 2021 15:05:00 提供 Nasdaq GlobeNewswire